Phathom Pharmaceuticals Inc (PHAT) — Financial Flexibility Index
Phathom Pharmaceuticals Inc (PHAT) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of $-14.09 Million (operating CF $-14.12 Million minus capex $27.00K) represents 0% of total liabilities ($662.82 Million). Check Phathom Pharmaceuticals Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Phathom Pharmaceuticals Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Phathom Pharmaceuticals Inc across 7 annual periods. For the full cash flow conversion analysis, see PHAT cash flow conversion.
Annual Financial Flexibility Index for Phathom Pharmaceuticals Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Phathom Pharmaceuticals Inc. Explore Phathom Pharmaceuticals Inc (PHAT) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.42x | $-266.63 Million | $-266.77 Million | $631.90 Million | ▼ -51.0% |
| 2023 | -0.28x | $-135.95 Million | $-137.58 Million | $486.60 Million | ▲ +54.0% |
| 2022 | -0.61x | $-145.49 Million | $-146.53 Million | $239.62 Million | ▲ +51.9% |
| 2021 | -1.26x | $-148.13 Million | $-148.46 Million | $117.28 Million | ▼ -85.5% |
| 2020 | -0.68x | $-68.65 Million | $-69.69 Million | $100.84 Million | ▼ -76.7% |
| 2019 | -0.39x | $-11.26 Million | $-36.51 Million | $29.22 Million | ▲ +5.4% |
| 2018 | -0.41x | $-891.00K | $-1.02 Million | $2.19 Million | — |